Meet the MedCity Media Team

And take 2 minutes to help us make better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Morning Read: Gingrich’s healthcare think tank sinks without him

7:37 am by | 0 Comments

The Center for Health Transformation filed for bankruptcy Wednesday in Atlanta, estimating it owes from $1 million to $10 million but has only as much as $100,000 in assets. Newt Gingrich was the chief fundraiser for the group that he started eight years ago, but resigned his post when he decided to run for president.

AVI Biopharma’s CEO is reconsidering the partnership offers from pharma companies interested in dystrophin, a drug to treat Duchenne Muscular Dystrophy. Chris Garabedian may have to shift away from his go-it-alone plan due to financial pressures and recent clinical trial results that didn’t impress Wall Street.

The Institute for Safe Medicine Practices says the Food and Drug Administration should limit the use of a new MS treatment based of a review of adverse event reporting from 2011. The group says that the non-profit says that the combination of a troubling safety profile before approval and dozens of cases of retinal injuries, infections and reduced blood pressure shows more patient monitoring is required. Read the Institute’s report here.


GE is buying a Houston company that provides contract genomic sequencing to advance its goal of developing technologies to better identify the genetic profile of cancers and other illnesses. SeqWright will continue its contract work with Eli Lilly and Roche.

Adam Bazih–doctor, entrepreneur and angel investor–recommends building the right team and learning to delegate to find success in the medical device industry. “My advice is to early on develop a clear road map, process charts, and a commercialization plan,” he told Medgadget in a recent interview.

[Image from flickr user Gage Skidmore]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Veronica Combs

By Veronica Combs

I am the editor in chief at I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.
Visit website | More posts by Author


Hear the latest news first

Get our daily newsletter or follow us.